Shots: The integration of innovative technologies in healthcare, such as digital health platforms and AI-enabled applications, is transforming the way diseases are detected, diagnosed, treated, and prevented The global Digital Health market is expected to reach $197.88B in 2025 and grow at a CAGR of 6.88%, reaching $258.25B by 2029 PharmaShots presents a concise report…
Shots:Transforming lives by leveraging cutting-edge technological advances, digital health companies have embarked on a journey to reshape the way we see and experience therapeuticsDigital health companies are fostering the use of highly innovative technologies in the healthcare system. In 2021, the global digital health therapeutics market was valued at $3.8B and is envisioned…
Shots:The past few years have shown an accelerated development in the digital therapeutics market through various applications, tracking devices, and telemedicine being integrated into digital therapiesDigital therapeutics provided powerful tools to maintain the public healthcare system during the Covid-19 pandemic for the people to access treatments for both physical & psychological conditions at home…
The recent decades have shown an accelerated development and evolution in the technology world- leading to unexpected growth in digital health companies.With the aid of health information technology- wearable devices- telehealth- telemedicine- and personalized medicine HCPs can make better insights for treatments and early diagnosis of life-threatening diseasesOur team at PharmaShots has categorized…
1. Pfizer Launched its Zirabev (biosimilar, bevacizumab) in the US by the year end 2019Date - Oct 01, 2019Product - Zirabev (biosimilar, bevacizumab)The biosimilar was launched in the US on Dec 31, 2019 following the settlement between Genentech and Pfizer granting all global rights of the product to the Pfizer. In Sept 2019,…

